Wednesday, August 23, 2023

Laboratory Information Systems Market by Size, Share, Trends, Competitive Landscape, Regional Analysis Forecasts to 2030

 

Market Scenario

The global laboratory information systems share is projected to grow USD 3.8694 billion by 2030 at CAGR of 9.50% during the forecast period 2023-2030, predicts Market Research Future (MRFR). There are several practice applications of an LIS that improve the day-to-day operations of a medical laboratory, along with prevention of medical errors. A busy medical laboratory having many patients on a regular basis encounter difficulty in keeping all the patients’ information organized. Thus, an LIS system comes in handy, as it helps keep all this information organized, which is vitally important for a medical lab to run smoothly. Apart from this, rising integration of LIS and Electronic Health Record (EHR) and demand for quality and precision diagnosis are majorly supplementing the market growth globally. Moreover, increasing penetration of mobile applications in healthcare solutions coupled with growing popularity of cloud-based laboratory information system testifies for the market progress that has taken place in the past few years.

On the flip side, lack of skilled information technology (IT) professionals in the healthcare industry tames the flow of the progressing Laboratory Information Systems Market Report. However, an array of opportunities stemming from emerging regions along with the consistently growing adoption of LIS are proof enough that the global market is en-route to brighter future prospects. Also noteworthy are few trends that bestow the global market with the required push, including proliferation of smartphones, point-of-care devices and e-services in the healthcare industry which significantly shape the market dynamics. Also, immense demand from patients for technological solutions for more convenient health testing, and monitoring is growing. This leads to global market players taking notice of the opportunities that crop up and indulge in strategic activities such as product launches. For instance, in the year 2014, Thermo Fisher launched a new ultracentrifuge which combines speed with safety and ergonomics that allows researchers to protect samples easily while also achieving reliable and consistent results.

Key Players

global laboratory information systems market players include   Cerner Corporation, Recent Developments, Eclipsys Corporation, Merge Healthcare Inc., STARLIMS Corporation, Sunquest Corporation and Thermo Fisher Scientific Inc., LabVantage Solutions Inc., LabWare Inc., McKesson Corporation, Medical Information Technology Inc., and others.

The Cerner EHR project is thriving as the U.S. Department of Defense increases its budget by about USD 1.2 billion. The additional funds will support the added services to maintain a standard EHR between the Department of Veterans Affairs and the U.S. Coast Guard. The EHR when integrated with laboratory information system, turns highly efficient, which leads to increased productivity and also reduced probability of errors. Cerner is an established company in the global LIS market that understands this fact and makes use of every opportunity to enhance its products to cater to various customer needs.

Market Segmentation

The global laboratory information systems market overview is segmented on the basis of application, components, and delivery.

By applications, the market is segmented based on clinical LIS, drug discovery LIS, and industrial LIS. The clinical application of LIS holds the largest market share as using LIS software involves more productivity and less paperwork, enhanced patient safety, and improved turn-around time.

By components, the market is segmented based on software, hardware, and services. Among these, the software segment accounts for the majority of the global LIS market due to increasing product enhancements and advent of innovative LIS software systems which ensures the smooth running of the healthcare department.

By delivery, the market is segmented on the basis of web-based, on-premise and cloud-based. Among these, cloud-based LIS software is highly popular as it offers various benefits such as cost savings, high security, flexibility, mobility and quality control.

Regional Analysis

By region, the global laboratory information systems market insights is segmented on the basis of North America, Europe, Asia Pacific and the Rest of the World (RoW).

The joint market share combining North America and Europe was more than 75% of the global total market size in 2014. However, North America has currently secured the top position claiming the largest market share. This stupendous growth can be attributed to increasing cases of fatal diseases and subsequent diagnostic and treatment needs. Moreover, high disposable income and strong economy also help augment the market growth in the region. Furthermore, increasing business opportunities for healthcare service providers along with growing demand for automated instruments rising in laboratories has majorly triggered the market growth in the region.

On the other hand, the Europe LIS market is estimated to grow tremendously during the forecast period, due to massive investment by healthcare IT players and a barrage of players trying to enter the regional market and establish themselves. Moreover, thriving healthcare industry and sophisticated medical infrastructure also play a major role in the growth of the regional market.

The Asia-marked Pacific is also presumed to grow at a significant pace throughout the forecast period. This growth is due to increased infectious diseases, significant increase in healthcare expenditure and advancements in healthcare IT sector. The market growth in the region is also aided by growing need for enhancing the efficiency of medical laboratories, growing demand for error-free diagnosis and increasing integration of information system with laboratories.

The rising aging population and increasing cases of fatal diseases in the regions of Middle East and Africa have propelled the market growth in the region. Also, the market in the region is highly fragmented, and the regional market players used various strategies such as product launches, expansions, and joint ventures to increase their footprint in the region. This gives a significant push to the market and will continue to do so in the coming years as well.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Tumor Ablation Market to Be Driven by Rising Use For Observation, Data Collection, And Intelligence In The Forecast Period Of 2023-2032

Market Overview

 The tumor ablation market is a rapidly growing market that is expected to reach a value of $4.07 billion by 2030. Tumor ablation is a minimally invasive procedure that uses heat, cold, or other energy to destroy cancer cells. It is a less invasive alternative to surgery and can be used to treat tumors in a variety of locations, including the liver, kidney, lung, and prostate.

Key Players

The tumor ablation market players include:

  • Medtronic Plc
  • Boston Scientific Corporation
  • AngioDynamics Inc.
  • Abbott
  • Merit Medical Systems
  • Galil Medical, Inc.
  • EDAP TMS SA
  • Hologic Inc.
  • SonaCare Technologies, Inc.
  • AtriCure, Inc.

These companies offer a variety of tumor ablation devices and technologies.

There are a number of factors driving the growth of the tumor ablation market, including:

  • Rising prevalence of cancer: The global cancer incidence is expected to reach 23.6 million cases by 2030. This increase in cancer cases is driving the demand for minimally invasive treatment options such as tumor ablation.
  • Improvements in technology: Technological advancements in tumor ablation devices are making the procedures more effective and safer. For example, new ultrasound-guided tumor ablation devices allow doctors to precisely target tumors with heat energy.
  • Preference for minimally invasive procedures: Patients are increasingly preferring minimally invasive procedures over surgery due to the shorter recovery time and lower risk of complications.
  • Cost-effectiveness: Tumor ablation is a cost-effective treatment option for many patients, especially those who are not good candidates for surgery.

The tumor ablation market is segmented by technology, treatment, application, and region. The technology segment is further segmented into radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, irreversible electroporation ablation (IRE), and others. The treatment segment is further segmented into surgical ablation, laparoscopic ablation, and percutaneous ablation. The application segment is further segmented into kidney cancer, liver cancer, breast cancer, lung cancer, and prostate cancer. The region segment is further segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America is the largest market for tumor ablation, followed by Europe and Asia Pacific. This is due to the high prevalence of cancer and the availability of advanced technology in these regions. The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period, due to the increasing incidence of cancer and the growing demand for minimally invasive procedures in this regions

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Service

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Corporate Wellness Market Players, Segmentation, Analysis by Recent Trends, Future Prospects, Growth, Development by Regions to 2032

Market Insights

The corporate wellness market size is a rapidly growing industry that provides a variety of services and programs designed to improve the health and well-being of employees. The market is expected to reach a value of \$74.9 billion by 2030, growing at a CAGR of 4.47% from 2023 to 2030.

There are a number of factors driving the growth of the corporate wellness market, including:

  • Rising awareness of the importance of employee health and well-being: Employers are increasingly recognizing the link between employee health and productivity. Studies have shown that unhealthy employees are more likely to miss work, take sick days, and have accidents. This can lead to significant financial losses for employers.
  • Increased prevalence of chronic diseases: Chronic diseases such as obesity, heart disease, and diabetes are on the rise in the workplace. These diseases can lead to high healthcare costs for employers. Corporate wellness programs can help employees prevent chronic diseases and manage their health conditions, which can save employers money.
  • Technological advancements: Technological advancements have made it easier to deliver corporate wellness programs to employees. For example, mobile apps and wearable devices can be used to track employee health data and provide personalized coaching and support.
  • Changing workforce demographics: The workforce is becoming more diverse, with a growing number of employees from different cultures and backgrounds. This makes it important for employers to offer corporate wellness programs that are tailored to the needs of their employees.
Segmentation

The corporate wellness market is segmented by service, delivery mode, end-user, and region. The service segment is further segmented into health risk assessment, health coaching, fitness and wellness programs, disease management, and others. The delivery mode segment is further segmented into on-site, off-site, and virtual. The end-user segment is further segmented into large enterprises, small and medium-sized enterprises (SMEs), and government organizations. The region segment is further segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America is the largest market for corporate wellness, followed by Europe and Asia Pacific. This is due to the high awareness of the importance of employee health and well-being in these regions. The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period, due to the increasing investment in corporate wellness by employers in this region.

Key Players

The corporate wellness market players include:

  • Wellness Corporate Solutions, LLC
  • EXOS
  • ComPsych Corporation
  • Virgin Pulse Inc.
  • Welltok, Inc.
  • LifeWorks, Inc.
  • Healthways, Inc.
  • Aetna Inc.
  • Cigna Corporation
  • UnitedHealth Group Inc.
  • Humana Inc.

These companies offer a variety of services and programs to help employers improve the health and well-being of their employees.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Process Analytical Technology Market Insights To Witness Notable Growth During the Forecast Period 2023-2032

 

Market summery

The Process Analytical Technology Market Size is projected to reach at 13.1% CAGR during the forecast period 2023-2032. The FDA defines process analytical technology (PAT) as a mechanism for designing, studying, and controlling pharmaceutical manufacturing processes by measuring essential process parameters that affect critical quality attributes of an active pharmaceutical component (API). The primary goal of process analytical technology is to reduce production cycling time, batch rejection and maximize automation. According to a report published by MRFR, the market is estimated to accomplish a formidable CAGR in the duration of the forecast period.

Process Analytical Technology Industry have played an essential role in the pharmaceutical industry's process development and scale-up of asymmetric syntheses of chiral compounds, including active medicinal ingredients. The necessity for automation and quality control in pharmaceutical manufacturing and escalating regulatory restrictions for drug manufacture and pharmaceutical production are powerful factors for the use of the process analytics sensors.

Competitive Analysis

Due to the return of COVID cases in many locations, the market may exhibit constrained growth. The continuation of occasional lockdowns in numerous regions may cause the market expansion to be hampered if resources such as labor and supply chains are severely impacted. The global market is expected to diversify in operational techniques as innovative models for operation and delivery are implemented. It is projected that the emphasis on accumulating reserves of resources to deal with unexpected crises would impact future market trends. Government assistance is expected to support worldwide market development in the next years. Market developments and research are expected to generate attractive growth opportunities in the next years. The reliance on online commerce for sales is expected to increase significantly during the forecast period, prompting market stakeholders to invest more in its growth.

The Process Analytical Technology Market Players are

·          PerkinElmer, Inc. (U.S.),

·          Thermo Fisher Scientific, Inc. (U.S.),

·          Agilent Technologies, Inc. (U.S.),

·          Bruker Corporation (U.S.), and

·          Danaher Corporation (U.S.).

Segmental Analysis

The segmentation of the Process Analytical Technology Market Insights is conducted on the basis of product, region, and application.

Based on application, the process analytical technology market consists of spectroscopy which is further segmented into molecular, mass, and atomic spectroscopy, chromatography which is further segmented into liquid and gas; electrophoresis, and particle size analysis.

The process analytical technology market consists of a sensor, probes, and analyzers based on product. Based on regions, the process analytical technology market consists of North America, Europe, Asia-Pacific, and other global markets.

Detailed Regional Analysis 

The regional assessment of the Process Analytical Technology Market Outlook consists of North America, Europe, Asia-Pacific, and other global markets. During the projected period, North America is estimated to account for the greatest share of the market. The presence of a large number of market participants and regulatory compliance pushing the use of PAT are fueling the growth of the North American market. However, the Asia-Pacific region is expected to increase the most during the forecast period. The Asia-Pacific market for process analytical technology has increased dramatically in recent years, owing to increased government funding in the biotech industry, an increase in the number of contract research and manufacturing institutions, and an increased focus of international players on emerging markets.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Nuclear Imaging Devices Market Share accelerating a CAGR during the forecast period 2023-2032

 

Market Highlights

The global Nuclear Imaging Devices Market Share is expected to grow significantly over the forecast period. It is anticipated that the market is projected to register a CAGR of 5.1% over the forecast period 2023-2032.

The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.

Various other factors such as the advancements in radiotracers, acceptance of nuclear imaging devices in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing investment on diagnostic imaging centers are also expected to propel the growth of the market.

However, the high cost of the nuclear imaging device, shorter half-life of radiopharmaceuticals can hamper market growth over the forecast period.

Key Players

the global nuclear imaging devices market players are

           ·          Philips Healthcare,

           ·          Digirad Corporation,

           ·          Neusoft Medical Systems Co., Ltd.,

           ·          Progenics Pharmaceuticals Inc.,

           ·          Cannon Inc.,

           ·          Surgiceye GmbH,

           ·          CMR Naviscan,

           ·          Mediso Medical Imaging Systems Ltd.,

           ·          Agfa-Gevaert Group,

           ·          General Electric Company,

           ·          DDD-Diagnostic A/S,

           ·          Spectrum Dynamics Medical,

           ·          FMI Medical Systems, Inc.,

           ·          Segamicorp, and others.

Segmentation

The global nuclear imaging devices market is segmented based on technology, application, end user, and region.

·         The global nuclear imaging devices market outlook, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy. The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.

·         Based on application, the market is segmented into oncology, cardiology, neurology, and others.

·         Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.

·         The diagnostic imaging centers segment is expected to witness the fastest growth over the forecast period due to rising adoption of nuclear imaging in diagnostic centers.

Regional Analysis

In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.

The nuclear imaging devices market insights in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European nuclear imaging devices market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The nuclear imaging devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The nuclear imaging devices market in the Middle East & Africa has been segmented into the Middle East and Africa.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Healthcare Information Systems Market Outlook, Trends, Size, Share, Players, Scope, Regional Demand and Forecast To 2032

 

Market Synopsis:

The healthcare information systems market share increase in adoption of the latest technologies in the healthcare sector is supposed to drive the growth of the healthcare information systems market in the foreseeable future. A report offered by Market Research Future (MRFR) indicates that the market is prognosticated to mark 12.90% CAGR over the forecast period 2023 to 2032. The developments in the healthcare IT industry is projected to drive the expansion of the healthcare information systems market in the upcoming years.

The healthcare system is growing at a rapid pace which has led to the generation of vast amount of data everyday. The efficient management of these data is one of the top-most priorities of healthcare organizations. Thus, the healthcare information software market is presumed to gain traction in the nearby future. In addition, rising number of patients on the global front, coupled with expansion of healthcare service providers, is expected to drive the augmentation of the healthcare information system market in the upcoming years.

The healthcare industry is expanding, which is supposed to motivate adoption of advanced technologies in the industry. This ongoing trend of technological development is supposed to drive the growth of the healthcare information systems market in the years to come. In addition, the introduction of the blockchain technology is set to revolutionize the healthcare information systems market in the coming years.

Competitive Dashboard:

The healthcare systems market players of the assessed in the report are Agfa-Gevaert N.V., Allscripts Healthcare Solutions Inc., Athenahealth Inc., Carestream Health, GE Healthcare, Cerner Corporation, Philips Healthcare, McKesson Corporation, NextGen Healthcare, Medidata Solutions Inc., and Siemens Healthineers.

Market Segmentation:

The type-based segments of the healthcare information systems market outlook are hospital information systems, laboratory information systems, pharmacy information systems, medical imaging information system, and revenue cycle management. The sub-segments of the hospital information systems segment are population health management, electronic health record, real-time healthcare, electronic medical record, patient engagement solutions, and others. The sub-segments of the pharmacy information systems segment are prescription management, inventory management, automated dispensing systems, and others. The sub-segmentation of the medical imaging information system covers monitoring analysis software, picture archiving & communication systems, radiology information systems, and others.

On the basis of component, the segments of the healthcare information systems market are software and hardware.

The deployment-based segments of the healthcare information systems market are on premise, web-based, and cloud-based.

The end-user segments of the healthcare information systems market identified are academic and research institution, hospitals, diagnostics center, and others.

Regional Analysis:

This report presents a detailed geographical analysis of the healthcare information systems market based on regions and further segmented into countries. The regional segments profiled for the study are – Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). Americas held the forefront position and is supposed to retain it. Increasing demand for quality diagnostics is one of the primary drivers of the healthcare information systems market in the region. In addition, the support extended by the governments is also supposed to drive market growth.

Asia Pacific is expected to observe a high rate of growth. It is due to the developments in the healthcare IT industry. Also, the rising demand for technological innovations in the industry is prognosticated to drive the growth of the healthcare information systems market in APAC. The MEA is supposed to hold the least share. However, the region resonates strong growth potential.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Single-Photon Emission Computed Tomography Market Share, Size, Trends, Industry Analysis Report, By End-Use; By Application; By Type; By Region; Segment by 2032

 

Market Highlights

 

Single-Photon Emission Computed Tomography Market Share is expected to reach at 6.90% CAGR during the forecast period 2023-2032.

The growing acceptance of Single-Photon Emission Computed Tomography (SPECT) accustomed by its technical advances is one of the major trends witnessed in the global SPECT market over the forecast period. Imaging devices are becoming more advanced, efficient, and evolved in terms of technology. The SPECT scanner has two integral parts namely computed tomography (CT) and a radioactive material (tracer). Basically, these tracers are used to diagnose and predict outcomes in various disease states by monitoring the therapeutic effects.

 

The Single-Photon Emission Computed Tomography market insights is expected to witness tremendous growth owing to the new 99mtc labelled agents for visualizing biologically significant events, and integration of X-ray tomography (CT) In SPECT. Other key factors such significant investments in R&D and expansions undertaken by key players are contributing towards the growth of the market. However, challenges such as need for skilled professionals, and reimbursement issues, is likely to curb the market growth during the forecast period.

 

Key players

 

The global market is manifested with the presence of limited companies, leading to the consolidated nature of the market. The industry rivalry are expected to remain high throughout the forecast period. Several small and larger companies are involved in development of Single-Photon Emission Computed Tomography (SPECT) for diagnostic applications.

 

The Single-Photon Emission Computed Tomography Market Players are GE Healthcare, Siemens Healthcare, Koninklijke Philips N.V., Bruker Corporation, Mediso Ltd., Digirad Corporation, Spectrum Dynamics Medical, DDD-Diagnostic A/S, MiE America, Inc., CardiArc, Beijing Hamamatsu Photon Techniques INC., SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.

PNPMedM, NuCare Inc., and others.

Segmentation

 

The global Single-Photon Emission Computed Tomography market outlook is segmented into type, application, end-users. The Single-Photon Emission Computed Tomography (SPECT) market, by type, the market is segmented into hybrid SPECT systems, and standalone SPECT systems. On the basis of application, the Single-Photon Emission Computed Tomography (SPECT) market is bifurcated into oncology, cardiology, neurology, and others. On the basis of end-user, the market is segmented into hospitals, diagnostic imaging centers, academic & research centers, and others.

 

Regional Analysis

 

The Americas is the largest in the market owing to the improving research infrastructure in the region, coupled with the rising awareness among patients and physicians for radioisotopes. Further, SPECT has reportedly been combined with CT and MRI to provide detailed anatomical and metabolic information. It is currently exhibiting a highly lucrative growth rate due to an increased use of SPECT for diagnosis of cardiac diseases, brain diseases, etc.

 

The European region is the second largest SPECT market over the forecast period due to high acceptance of SPECT in research & development along with the rising incidence of chronic disease like cancers are also accountable for the growth of the Single-Photon Emission Computed Tomography (SPECT) market. 

The Asia Pacific region is likely to develop at the uppermost CAGR for the Single-Photon Emission Computed Tomography (SPECT) market in the years to come. Moreover, the rising diagnostic care services both at the hospitals and at community level are expected to influence the market in a positive way. The Middle East and Africa accounts for the least market share due to low per capita income and lack of availability of well-trained healthcare professionals.

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

Growing Adoption of Non-Invasive Tattoo Removal Techniques: Market Implications

Tattoo Removal Market: Overview and Trends The tattoo removal market is a dynamic and growing sector within the global aesthetics industry...